Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Donald Trump scores big win in South Carolina Republican primary
    • Global house prices rebound as economists predict turning point
    • Trump says he is a ‘dissident’ under siege from thugs in bleak speech
    • Malaysia’s prime minister decries ‘China-phobia’ among US and western allies
    • Trump pivots to race against Biden after crushing Haley in South Carolina
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
    Most Read
    • UK Conservatives battle to retain ‘true blue’ rural heartlands
    • Conservative party suspends Lee Anderson over Sadiq Khan comments
    • UK deputy PM declines to say if Lee Anderson comments over Sadiq Khan were racist
    • Birth rate drops to new low in England and Wales
    • ‘Macho’ all-male Rochdale by-election fuels political divisions over Gaza
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Jim Ratcliffe warns EU bureaucracy will drive away industry’s investments
    • Warren Buffett admits Berkshire Hathaway’s days of ‘eye-popping’ gains are over
    • Indonesia to wipe out global nickel rivals, warns French miner Eramet chief
    • Goldman insider-trading conviction shows UK watchdog sharpening its teeth
    • European football needs innovation and drama, says Real Madrid and FC Barcelona investor
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Indonesia to wipe out global nickel rivals, warns French miner Eramet chief
    • How Germany’s steelmakers plan to go green
    • Goldman insider-trading conviction shows UK watchdog sharpening its teeth
    • $100mn in crypto payments traced to Myanmar-based ‘scammers’
    • Public service pensions are the elephant in the room
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why is Nikki Haley still running?
    • Western timidity has only emboldened Putin
    • The global trade system is in desperate need of an overhaul
    • The forgotten war
    • The metropolitan elite has ignored farmers for too long
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Fewer trips, fewer planes: business travellers rethink old habits
    • The menace of the overblown job title
    • ‘Every person slips at some point’: how businesses are managing the four-day week
    • ‘The one thing I’ve always had is deal flow’: RedBird’s Gerry Cardinale
    • Good news. We’ve got the contract for the worst idea in the world
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Zone of Interest director Jonathan Glazer: ‘I’m suspicious of people making Holocaust films’
    • Six cool California hotels to book now
    • Across ‘Saxon Switzerland’ in the footsteps of Caspar David Friedrich
    • Can a friendship app cure loneliness?
    • ‘They are among us’: Russia’s terrifyingly effective poisoning operation
  • HTSI
  1. Companies
  2. Health
  • Healthcare
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Health

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 9 February, 2024
    HTSIBig spring energy – an HTSI style special
    When the gym is your catwalk

    Let the locker room be your inspiration with these easy fits

    Miu Miu suede coat, £6,000, crepe de Chine dress, £3,550, and nylon swim briefs, £600. Alex Eagle Sporting Club organic cotton jersey Richmond T-shirt, £75
  • Thursday, 8 February, 2024
    HTSI
    Michelle Yeoh on the quiet power of martial arts

    The Oscar-winning actor describes why wing chun works for mind, body – and cinema

    Yeoh with dancers from the Shenzhen Opera and Dance Theatre in her new short film, Be Spring
  • Thursday, 8 February, 2024
    War in Ukraine
    UK to scrap Covid intensive care kit despite offer to send to Ukraine

    Machines lack a CE certification showing they comply with EU performance and safety directives

    A patient in a hospital bed wears a CPAP device
  • Wednesday, 7 February, 2024
    UK employment
    Trainee nurses in England forced to quit over spiralling childcare costs

    Experts warn ‘patients will suffer’ as students drop out and nursing course acceptances fall by 12%

    Leanne Bibby, a student nurse who is unable to access funded childcare hours, is seated on a sofa.
  • Tuesday, 6 February, 2024
    Israel-Hamas war
    Gazans search in vain for medicines

    Cancer, diabetes and heart disease patients among those facing chronic shortage of treatments

    Palestinians wait to buy medicine as pharmacies are mostly empty because of the drug supply shortage
  • Tuesday, 6 February, 2024
    LexPharmaceuticals sector
    Big Pharma still needs trial success to overcome looming patent panic Premium content

    Pharma companies, while talking up pipelines, are turning to deals to boost their growth outlook

    A Bristol Myers Squibb sign on a facility in Cambridge, Massachusetts, US
  • Monday, 5 February, 2024
    Moral Money
    Can impact investors help us age? Premium content

    Growing elderly populations could bring fertile opportunities for impact financiers

    Elderly people exercising in a line
  • Monday, 5 February, 2024
    Experts warn of ‘appalling decline’ in child health in UK

    More than a fifth of five-year-olds are overweight or obese, with one in four suffering from tooth decay, study shows

    Children play on their scooters in Leeds
  • Sunday, 4 February, 2024
    Novo Nordisk AS
    Novo Nordisk ‘surprised’ by high European demand for weight-loss drugs

    Chief executive says customers very willing to pay for Wegovy from their own pockets

    Injection pens and boxes of Novo Nordisk’s weight-loss drug Wegovy
  • Saturday, 3 February, 2024
    News in-depthHealthcare
    Wealthier adults drive sharp rise in demand for ADHD drugs

    Number of prescriptions in England has increased 3 times faster than expected since 2021

  • Friday, 2 February, 2024
    Jo Ellison
    The fasting and the furious

    Rishi Sunak’s diet ‘revelations’ serve to expose old gender norms 

    A man drinks water from a glass
  • Friday, 2 February, 2024
    Advances in UK cancer survival fall sharply

    Progress is at slowest rate in almost half a century, Cancer Research data shows

    A consultant analyses a mammogram
  • Thursday, 1 February, 2024
    Manica Balasegaram
    Antibiotic resistance is the greatest threat to cancer patients

    Investing in new oncology drugs without building up an effective arsenal against infections is a false economy

    A nurse hangs a bag of medicine
  • Thursday, 1 February, 2024
    FT Magazine
    Ovaries are an enigma that could unlock human lifespan

    Philanthropist Nicole Shanahan is spending $100mn to find answers to fundamental questions about ovaries

  • Wednesday, 31 January, 2024
    Medical science
    Scientists use Crispr gene editing to treat hereditary disorder

    Huge reduction in bouts of angioedema increases prospect that technique can combat a range of diseases

    Confocal Fluorescence Microscopy of Crispr- generated knockout cells
  • Wednesday, 31 January, 2024
    Joy Lo Dico
    Pests remind us we’re not in total control of our cities

    Rat anxiety has increased in the UK since a cold snap sent more into our homes. But they’re a testament to our abundance — and waste

  • Wednesday, 31 January, 2024
    AstraZeneca PLC
    AstraZeneca wrongfully dismissed senior scientist, tribunal finds

    James Muir was discriminated against on the basis of his mental health disability

    Astrazeneca logo on a building
  • Wednesday, 31 January, 2024
    Novo Nordisk AS
    Novo Nordisk shares hit record high as weight-loss drugs power profits

    Danish drugmaker reports better than expected earnings for 2023

    Three injection pens of Wegovy, one lies at an angle on top of two others
  • Wednesday, 31 January, 2024
    Untold podcast44 min listen
    Ten Long Days

    Madison hears from others who claim they suffered after going on meditation retreats

  • Monday, 29 January, 2024
    Sustainability
    Radical food system overhaul would raise costs but deliver $10tn a year benefit, report says

    Report estimates one-third rise in commodity prices by 2050 would be compensated by health and nature savings

    A French farmer blocks a motorway on Monday, with a sign reading ‘Save agriculture, France is hungry’.
  • Monday, 29 January, 2024
    Dementia
    Alzheimer’s was passed between humans in now-banned procedure, study finds

    Cases connected to growth hormone extracted from cadavers show disease’s parallels with CJD brain disorder

    Someone holding up a brain scan
  • Monday, 29 January, 2024
    GSK PLC
    GSK’s new RSV jab set to achieve blockbuster status

    Strong uptake of UK pharma group’s vaccine has helped to ease fears of a patent cliff

    The GSK company logo
  • Sunday, 28 January, 2024
    The FT ViewThe editorial board
    The worrying return of a nasty virus

    Better awareness and access are needed to rebuild measles vaccination rates

    A toddler in her mothers arms while she is inoculated in the arm
  • Sunday, 28 January, 2024
    GSK PLC
    GSK refuses to join Ireland’s mother and baby home compensation scheme

    Forerunners of pharma company tested vaccines at notorious institutions for decades

    Francis Timmons looks left out of his lounge window while sitting on a sofa. He holds a framed photograph of his mother
  • Sunday, 28 January, 2024
    Pilita Clark
    We should have fixed jet lag by now

    Science has put a cure in reach if we can just work out how to use it

    Illustration of a sleeping person in the shape of a plane flying head-first towards a bed
Previous page You are on page 2 Next page

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Building Resilient Healthcare Systems
Localising health supply chains in ME, Central Asia, Türkiye, PK & Afghanistan
Monday, 26 FebruaryDigital Conference
FT Live
Strategies to Address Obesity in America’s Workforce
Tackling the business and health impacts
Wednesday, 28 FebruaryNew York
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board NetworkBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • UK
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In